PARP targeted alpha-particle therapy enhances response to PD-1 immune-checkpoint blockade in a syngeneic mouse model of glioblastoma H Dabagian, T Taghvaee, P Martorano, D Martinez, M Samanta, ... ACS Pharmacology & Translational Science 4 (1), 344-351, 2021 | 32 | 2021 |
Functional polyethylenes with precisely placed thioethers and sulfoniums through thiol–ene polymerization MT Kwasny, CM Watkins, ND Posey, ME Matta, GN Tew Macromolecules 51 (11), 4280-4289, 2018 | 20 | 2018 |
Fluorescent peptomer substrates for differential degradation by metalloproteases MJ Austin, H Schunk, C Watkins, N Ling, J Chauvin, L Morton, ... Biomacromolecules 23 (11), 4909-4923, 2022 | 3 | 2022 |
Exploring alpha-particle therapy in combination with immune checkpoint blockade in an immunocompetent model of glioblastoma H Dabagian, A Mansfield, P Martorano, T Tahgvaee, R Chai, N Yoon, ... Journal of Nuclear Medicine 61 (supplement 1), 1208-1208, 2020 | | 2020 |